Home - Oncology Central

23 NOV 2021Research Article / Future Oncology
Real-world assessment of myelodysplastic syndrome: Japanese claims data analysis
16 NOV 2021Clinical Trial Protocol / Future Oncology
DUART: durvalumab after radiotherapy in patients with unresectable, Stage III NSCLC who...
27 OCT 2021Review / Future Oncology
A call to action: antiracist patient engagement in adolescent and young adult...
15 NOV 2021Plain Language Summary / Future Oncology
Plain Language Summary of the INVICTUS study: ripretinib for advanced gastrointestinal stromal...
22 SEP 2021Research Article / Future Oncology
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma...
11 AUG 2021Perspective / Future Oncology
Ixazomib-lenalidomide-dexamethasone in routine clinical practice
19 AUG 2021Plain Language Summary / Future Oncology
Plain language summary of the final results from the DESTINY-Breast01 study
1 SEP 2021Plain Language Summary / Future Oncology
Plain language summary of the GARNET trial: clinical activity and safety of...
9 SEP 2021Research Article / Future Oncology
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric...

Featured

5 NOV 2021 FOR CLINICIANS / PODCAST

Key challenges and opportunities to advance bladder cancer care

11 OCT 2021 IN FOCUS

In Focus: recent therapies in renal cell carcinoma

14 JUL 2021 SPOTLIGHT

Spotlight on clinical trials

24 FEB 2021 IN FOCUS

Publication In Focus: GioTag

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/02/Copy-of-Untitled-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

15 FEB 2021
IN FOCUS 
Publication In Focus: INSIGHT MM

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/5-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
BIOMARKERS
/ PODCAST 
OCTalks: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/in-association-with-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
IN FOCUS 
In Focus: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-10-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="FGFR2" /> 

21 OCT 2020
CLINICAL TRIALS
/ PODCAST 
OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/09/Untitled-design-34-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="COVID-19 ethics" /> 

8 SEP 2020
CLINICAL TRIALS
/ PODCAST 
OCTalks: the ethical impact of COVID-19 on the cancer field

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/04/580x580-8-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

8 AUG 2020
IN FOCUS 
In Focus: coronavirus

Must Watch

21 OCT 2021 WEBINAR

Coffee Chat: the unmet needs of the EGFR-positive NSCLC patient population

21 SEP 2021 WEBINAR

Coffee Chat: mental health in the oncology clinic

25 AUG 2021 WEBINAR

Panel discussion: setting the roadmap for optimizing cancer clinical trials

11 AUG 2021 DRUG DEVELOPMENT / VIDEO

Ixazomib-lenalidomide-dexamethasone in routine clinical practice

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/08/feature_image_ICON_WEBINAR-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

6 AUG 2021
CLINICAL TRIALS
/ WEBINAR 
The changing face of cell and gene therapy: impacts on planning and executing trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

26 MAY 2021
LUNG
/ VIDEO 
Afatinib in NSCLC with uncommon EGFR mutations

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

25 MAY 2021
CLINICAL TRIALS
/ VIDEO 
Sequential afatinib and osimertinib in NSCLC patients

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

30 MAR 2021
CLINICAL TRIALS
/ VIDEO 
Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/12/eventpage_OC_Agendia_panel_3Feb-1-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

24 DEC 2020
CHEMOTHERAPY
/ WEBINAR 
Panel discussion: real-world data in clinical trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-64-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="Managing colorectal cancer patients" /> 

2 OCT 2020
COLORECTAL
/ VIDEO 
Managing colorectal cancer patients in the COVID-19 era

Top 10 clinical oncology news articles of 2021

NICE recommends Osimertinib (Tagrisso®) for EGFR+ Stage 1b–3A NSCLC within the Cancer Drugs Fund

Top 3 drug approvals in November 2021 – Fyarro™, Tagrisso® and Retsevmo

Could over-the-counter antihistamines improve immuno-oncology results?

Real-world assessment of myelodysplastic syndrome: Japanese claims data analysis

Establishing best-practice guidelines for antiracist patient engagement in AYA oncology research

Key challenges and opportunities to advance bladder cancer care

Immuno-oncology: what have been the top advancements in 2021?

Panel discussion: setting the roadmap for optimizing cancer clinical trials

Journal Content

Featured

Key challenges and opportunities to advance bladder cancer care

In Focus: recent therapies in renal cell carcinoma

Spotlight on clinical trials

Publication In Focus: GioTag

Publication In Focus: INSIGHT MM

OCTalks: Comprehensive Genomic Profiling

In Focus: Comprehensive Genomic Profiling

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

OCTalks: the ethical impact of COVID-19 on the cancer field

In Focus: coronavirus

Must Watch

Coffee Chat: the unmet needs of the EGFR-positive NSCLC patient population

Coffee Chat: mental health in the oncology clinic

Panel discussion: setting the roadmap for optimizing cancer clinical trials

Ixazomib-lenalidomide-dexamethasone in routine clinical practice

The changing face of cell and gene therapy: impacts on planning and executing trials

Afatinib in NSCLC with uncommon EGFR mutations

Sequential afatinib and osimertinib in NSCLC patients

Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

Panel discussion: real-world data in clinical trials

Managing colorectal cancer patients in the COVID-19 era

Office info

Journal Content

Featured

Must Watch

What's Trending?